CN102578319B - 一种银杏普洱生茶及其制备方法 - Google Patents
一种银杏普洱生茶及其制备方法 Download PDFInfo
- Publication number
- CN102578319B CN102578319B CN 201210039386 CN201210039386A CN102578319B CN 102578319 B CN102578319 B CN 102578319B CN 201210039386 CN201210039386 CN 201210039386 CN 201210039386 A CN201210039386 A CN 201210039386A CN 102578319 B CN102578319 B CN 102578319B
- Authority
- CN
- China
- Prior art keywords
- tea
- raw
- ginkgo
- raw material
- ginkgo leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000194101 Ginkgo biloba Species 0.000 title claims abstract description 100
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 244000269722 Thea sinensis Species 0.000 title description 138
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 96
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 94
- 238000000034 method Methods 0.000 claims abstract description 14
- 230000008569 process Effects 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241001122767 Theaceae Species 0.000 claims abstract 30
- 241000218628 Ginkgo Species 0.000 claims abstract 29
- 239000002994 raw material Substances 0.000 claims description 41
- 239000000203 mixture Substances 0.000 claims description 27
- 238000005303 weighing Methods 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 17
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- -1 polypropylene Polymers 0.000 claims description 8
- 238000003825 pressing Methods 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 8
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 7
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 7
- 239000004571 lime Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 29
- 230000036541 health Effects 0.000 abstract description 20
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 206010039966 Senile dementia Diseases 0.000 abstract description 4
- 239000003205 fragrance Substances 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 4
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 235000019789 appetite Nutrition 0.000 abstract description 3
- 230000036528 appetite Effects 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 208000015337 arteriosclerotic cardiovascular disease Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 134
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 21
- 235000020339 pu-erh tea Nutrition 0.000 description 21
- 239000000047 product Substances 0.000 description 19
- 239000011449 brick Substances 0.000 description 15
- 239000000843 powder Substances 0.000 description 11
- 238000012856 packing Methods 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 230000035622 drinking Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000009461 vacuum packaging Methods 0.000 description 5
- IWEIJEPIYMAGTH-UHFFFAOYSA-N Bilobetin Chemical compound COC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 IWEIJEPIYMAGTH-UHFFFAOYSA-N 0.000 description 4
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical group O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 208000034189 Sclerosis Diseases 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 2
- 229960001214 clofibrate Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000007955 flavonoid glycosides Chemical group 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229930184727 ginkgolide Natural products 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- ORQIZUYAGXZVPI-LBPRGKRZSA-N Bilobanon Natural products O1C(CC(C)C)=CC([C@@H]2CC(=O)C(C)=CC2)=C1 ORQIZUYAGXZVPI-LBPRGKRZSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- ORQIZUYAGXZVPI-UHFFFAOYSA-N bilobanone Natural products O1C(CC(C)C)=CC(C2CC(=O)C(C)=CC2)=C1 ORQIZUYAGXZVPI-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 description 1
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 description 1
- 239000011499 joint compound Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Tea And Coffee (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210039386 CN102578319B (zh) | 2012-02-21 | 2012-02-21 | 一种银杏普洱生茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210039386 CN102578319B (zh) | 2012-02-21 | 2012-02-21 | 一种银杏普洱生茶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102578319A CN102578319A (zh) | 2012-07-18 |
CN102578319B true CN102578319B (zh) | 2013-05-29 |
Family
ID=46467999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210039386 Active CN102578319B (zh) | 2012-02-21 | 2012-02-21 | 一种银杏普洱生茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102578319B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104206567A (zh) * | 2013-06-05 | 2014-12-17 | 上海锦医堂投资管理有限公司 | 一种养身茶及其制备方法 |
CN104012715A (zh) * | 2014-06-19 | 2014-09-03 | 南京麦思德餐饮管理有限公司 | 一种解酒茶 |
CN104431003A (zh) * | 2014-12-25 | 2015-03-25 | 保山昌宁红茶业集团有限公司 | 一种冬茶的制备方法 |
CN106551059A (zh) * | 2015-11-02 | 2017-04-05 | 广西誉槿缘茶业有限公司 | 茉莉普洱茶制作方法 |
CN108782869A (zh) * | 2018-07-13 | 2018-11-13 | 杨永定 | 石斛养生茶 |
CN113331277A (zh) * | 2021-07-03 | 2021-09-03 | 石家庄市五龙体育器材有限公司 | 一种功夫茶及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101133767A (zh) * | 2006-09-01 | 2008-03-05 | 颜廷和 | 一种银杏养生茶及其制备方法 |
CN101317615A (zh) * | 2007-06-08 | 2008-12-10 | 上海中医药大学 | 一种银棘茶饮料及其制备方法 |
CN101703123A (zh) * | 2009-11-03 | 2010-05-12 | 王德荣 | 枸杞银杏保健养生茶及其制备方法 |
-
2012
- 2012-02-21 CN CN 201210039386 patent/CN102578319B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101133767A (zh) * | 2006-09-01 | 2008-03-05 | 颜廷和 | 一种银杏养生茶及其制备方法 |
CN101317615A (zh) * | 2007-06-08 | 2008-12-10 | 上海中医药大学 | 一种银棘茶饮料及其制备方法 |
CN101703123A (zh) * | 2009-11-03 | 2010-05-12 | 王德荣 | 枸杞银杏保健养生茶及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102578319A (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102578319B (zh) | 一种银杏普洱生茶及其制备方法 | |
CN103555487B (zh) | 一种复方红葡萄酒的制造工艺 | |
CN102578321B (zh) | 一种银杏黑茶及其制备方法 | |
CN102630776A (zh) | 一种银杏叶提取工艺及银杏黑茶的加工方法 | |
CN102626151A (zh) | 一种银杏叶提取工艺及银杏绿茶的加工方法 | |
CN105325608A (zh) | 一种陈皮老姜茶及其制备方法和应用 | |
CN102578318B (zh) | 一种银杏普洱熟茶及其制备方法 | |
CN105055897B (zh) | 一种防治糖尿病的保健茶片及其制备方法 | |
CN102578325B (zh) | 一种银杏红茶及其制备方法 | |
CN102550739B (zh) | 一种银杏绿茶及其制备方法 | |
CN106106934A (zh) | 一种保健养生茶及其制备方法 | |
CN102578324B (zh) | 一种银杏黄茶及其制备方法 | |
CN104336213A (zh) | 一种灵芝保健茶及其制备方法 | |
CN102578320B (zh) | 一种银杏白茶及其制备方法 | |
KR20110056908A (ko) | 다시마, 함초, 귤피, 당귀, 옥수수수염, 뽕잎 및 삼백초으로 이루어진 한방 혼합 침출차 조성물 및 그 제조방법 | |
CN102578322B (zh) | 一种银杏乌龙茶及其制备方法 | |
CN102626156A (zh) | 一种银杏叶提取工艺及银杏普洱熟茶的加工方法 | |
CN102550763B (zh) | 一种银杏苦丁茶及其制备方法 | |
CN102578323B (zh) | 一种银杏雪茶及其制备方法 | |
CN102626153A (zh) | 一种银杏叶提取工艺及银杏红茶的加工方法 | |
CN102630777A (zh) | 一种银杏叶提取工艺及银杏白茶的加工方法 | |
CN102613349B (zh) | 一种银杏大蒜黄茶复合颗粒饮料 | |
CN102613339B (zh) | 一种银杏大蒜普洱熟茶复合颗粒饮料 | |
CN102626155A (zh) | 一种银杏叶提取工艺及银杏普洱生茶的加工方法 | |
CN102626154A (zh) | 一种银杏叶提取工艺及银杏黄茶的加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhinian Inventor after: Zhang Kuichang Inventor before: Zhang Kuichang Inventor before: Zhang Zhinian |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG KUICHANG ZHANG ZHINIAN TO: ZHANG ZHINIAN ZHANG KUICHANG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240104 Address after: 221354 Suyangshan Industrial Park, Pizhou City, Xuzhou, Jiangsu Province Patentee after: Pizhou Xingyuan Enterprise Management Service Co.,Ltd. Address before: 221300 east of Zaosi Road, suyangshan Town, Pizhou City, Xuzhou City, Jiangsu Province Patentee before: XUZHOU GREEN FIELD BIOLOGY Co.,Ltd. |